Food and Beverage News and Trends — FDA guidance ‘chaos for manufacturers’; and more
By Stefanie Jill Fogel and Mary B Langowski
This regular publication by DLA Piper lawyers focuses on helping clients navigate the ever-changing business, legal and regulatory landscape.
In 2009, the US Food and Drug Administration (FDA) told manufacturers not to use the term ‘evaporated cane juice’ on the grounds that the term could be used to conceal the fact that a product contains added sugar. The Grocery Manufacturers Association (GMA) and several industry members, in a 92-page filing at the FDA on 6 May, say the FDA’s view of that term, while expressed in good faith, has opened the industry up to lawsuits and ‘caused chaos for manufacturers’. They also assert that ‘evaporated cane juice’ is the common, defensible and acceptable name for the ingredient and should be allowed. Some companies have changed their labels in response to the FDA’s views, while others have kept the status quo until the FDA’s position is final…
Click on the link below to read the rest of the DLA Piper briefing.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from DLA Piper
News from The Lawyer
Briefings from DLA Piper
Health Alert — Julia Clare v Australian Community Pharmacy Authority; Dr Reid v Medical Council of NSW; and more
DLA Piper has released the 22 December 2014 issue of its Health Alert, which focuses on judgments, legislation and reports in the health sector.
The European Court of Justice (CJEU) has handed down a landmark judgment concerning the patentability of stem cells in Europe.
Analysis from The Lawyer
Regulators are ramping up the pressure in the aftermath of recession, leaving firms to compete for compliance and restructuring work
Shearman & Sterling is making its presence felt in the City, squaring up to magic circle firms and looking to muscle in on key relationships. Private equity house Bridgepoint is one outfit that has had its head turned by the US firm.